Evolución de la terapia fotodinámica en el manejo de la queratosis actínica ¿qué tan efectiva y segura es según la evidencia actual? Evolution of photodynamic therapy in the management of actinic keratosis: how effective and safe is it according to current evidence?     |     光动力疗法在光化性角化病管理中的发展：根据当前证据，其有效性和安全性如何？

Laura Valentina  Vargas-Monroy; Andrés Felipe  Londoño-Serna; Duvan Alejandro  Grisales-Cano; Carlos Andrés  Jaraba-Herazo; Ivan Andres  Peña-Chamorro; Max Jesus  Bustillo-Orozco; Zulmy Valeria  Montenegro-Salcedo; Michael Ortega-Sierra

doi:10.25176/RFMH.v24i4.6016

Authors

Laura Valentina Vargas-Monroy Universidad Nacional de Colombia
Andrés Felipe Londoño-Serna Remington University Corporation
Duvan Alejandro Grisales-Cano Cooperative University of Colombia
Carlos Andrés Jaraba-Herazo University of Applied and Environmental Sciences
Ivan Andres Peña-Chamorro University of Cartagena
Max Jesus Bustillo-Orozco University of the North
Zulmy Valeria Montenegro-Salcedo University of Cauca
Michael Ortega-Sierra Universidad Centroccidental Lisandro Alvarado

DOI:

https://doi.org/10.25176/RFMH.v24i4.6016

Keywords:

Phototherapy, Actinic Keratosis, Therapeutics, Safety, Efficacy

Abstract

Actinic keratosis is a premalignant dermatological condition characterized by the potential to progress to squamous cell carcinoma. To date, there is no treatment with an adequate benefit-risk balance. Photodynamic therapy is proposed as one of the most effective therapeutic tools. However, there is still divergence regarding the quality of available evidence. The objective of this review is to analyze the most recent evidence on the therapeutic performance of photodynamic therapy in the management of actinic keratosis. A literature search was conducted in the PubMed, Scopus, and MEDLINE databases. Based on the most recent randomized controlled trial comparing the use of dynamic phototherapy combined with aminolevulinic acid without incubation versus incubation for one hour, it was found that the intervention group had a higher percentage of lesion resolution compared to the control group (49.5% vs. 34.9%, p=0.002), as well as less pain in the intervention group (p=0.03). In addition, a similar trend was observed in other studies, suggesting that this therapy could be effective and beneficial in the management of actinic keratosis. Despite the limited and heterogeneous evidence regarding the use of dynamic phototherapy and its various combined regimens for the management of actinic keratosis, there is a clear trend towards potential benefits compared to other therapies.

Downloads

Download data is not yet available.

Author Biographies

Laura Valentina Vargas-Monroy, Universidad Nacional de Colombia

General Physician

Andrés Felipe Londoño-Serna, Remington University Corporation

General Physician

Duvan Alejandro Grisales-Cano, Cooperative University of Colombia

General Physician

Carlos Andrés Jaraba-Herazo, University of Applied and Environmental Sciences

General Physician

Ivan Andres Peña-Chamorro , University of Cartagena

General Physician

Max Jesus Bustillo-Orozco, University of the North

General Physician

Zulmy Valeria Montenegro-Salcedo, University of Cauca

General Physician

Michael Ortega-Sierra, Universidad Centroccidental Lisandro Alvarado

General Physician

References

Marques E, Chen TM. Actinic Keratosis. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557401/

Del Regno L, Catapano S, Di Stefani A, Cappilli S, Peris K. A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions. Am J Clin Dermatol. 2022; 23(3):339-352. doi: 10.1007/s40257-022-00674-3

Reinehr CPH, Bakos RM. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects. An Bras Dermatol. 2019; 94(6):637-657. doi: 10.1016/j.abd.2019.10.004

Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. 2017; 177(2):350-358. doi: 10.1111/bjd.14852

Han H, Berman B. Clinical Management of Actinic Keratosis: Review and Update. SKIN The Journal of Cutaneous Medicine. 2022; 6(4):274–285. doi: 10.25251/skin.6.4.1

Mosaddad SA, Mahootchi P, Rastegar Z, Abbasi B, Alam M, Abbasi K, et al. Photodynamic Therapy in Oral Cancer: A Narrative Review. Photobiomodul Photomed Laser Surg. 2023; 41(6):248-264. doi: 10.1089/photob.2023.0030

Osuchowski M, Bartusik-Aebisher D, Osuchowski F, Aebisher D. Photodynamic therapy for prostate cancer - A narrative review. Photodiagnosis Photodyn Ther. 2021; 33:102158. doi: 10.1016/j.pdpdt.2020.102158

Fayter D, Corbett M, Heirs M, Fox D, Eastwood A. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess. 2010; 14(37):1-288. doi: 10.3310/hta14370

Mpourazanis G, Konschake W, Vogiatzis R, Papalexis P, Georgakopoulou VE, Ntritsos G, et al. The Role and Effectiveness of Photodynamic Therapy on Patients With Actinic Keratosis: A Systematic Review and Meta-Analysis. Cureus. 2022; 14(6):e26390. doi: 10.7759/cureus.26390

Anvery N, Christensen RE, Dirr MA, Yi MD, Johnson T, Weil A, et al. Comparative effectiveness of 5-aminolevulinic acid photodynamic therapy with no incubation versus one-hour incubation for the treatment of actinic keratosis: A randomized controlled trial. J Am Acad Dermatol. 2023; 89(2):401-403. doi: 10.1016/j.jaad.2023.03.056

Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013; 68(1 Suppl 1):S2-9. doi: 10.1016/j.jaad.2012.09.052

Lampley N, Rigo R, Schlesinger T, Rossi AM. Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence. Dermatol Surg. 2023; 49(2):124-129. doi: 10.1097/DSS.0000000000003677

Wenande E, Togsverd-Bo K, Hastrup A, Lei U, Philipsen PA, Haedersdal M. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study. Dermatology. 2023; 239(3):393-402. doi: 10.1159/000529369

Li Y, Wang J, Xiao W, Liu J, Zha X. Risk Factors for Actinic Keratoses: A Systematic Review and Meta-Analysis. Indian J Dermatol. 2022; 67(1):92. doi: 10.4103/ijd.ijd_859_21

Hashim PW, Chen T, Rigel D, Bhatia N, Kircik LH. Actinic Keratosis: Current Therapies and Insights Into New Treatments. J Drugs Dermatol. 2019; 18(5):s161-166.

Nguyen M, Sandhu SS, Sivamani RK. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis - a review of the literature. Clin Cosmet Investig Dermatol. 2019; 12:427-435. doi: 10.2147/CCID.S16749

de Oliveira ECV, da Motta VRV, Pantoja PC, Ilha CSO, Magalhães RF, Galadari H, et al. Actinic keratosis - review for clinical practice. Int J Dermatol. 2019; 58(4):400-407. doi: 10.1111/ijd.14147

Sinclair R, Baker C, Spelman L, Supranowicz M, MacMahon B. A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. Australas J Dermatol. 2021; 62(2):119-123. doi: 10.1111/ajd.13447

Arcuri D, Ramchatesingh B, Lagacé F, Iannattone L, Netchiporouk E, Lefrançois P, et al. Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review. Int J Mol Sci. 2023; 24(5):4989. doi: 10.3390/ijms24054989

Steeb T, Petzold A, Hornung A, Wessely A, Berking C, Heppt MV. Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials. Sci Rep. 2022; 12(1):5884. doi: 10.1038/s41598-022-09722-8

Ericson MB, Wennberg AM, Larkö O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008; 4(1):1-9.

Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2

Galitzer BI. Photodynamic Therapy for Actinic Keratoses of the Upper Extremities using 10% Aminolevulinic Acid Gel, Red Light, and Adapalene Pretreatment. J Clin Aesthet Dermatol. 2021; 14(10):19-24.

Kiss N, Farkas K, Tosti G, De Gado F, Bergler-Czop B, Fazia G, et al. Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis. J Clin Med. 2022; 11(11):3164. doi: 10.3390/jcm11113164

Salman S, Sarsik SM, El-Qushayri AE, Sakr S, Ghozy S, Salem ML. Safety and efficacy of the combination of cryotherapy and photodynamic modalities with imiquimod in patients with actinic keratosis: a systematic review and meta-analysis. Ital J Dermatol Venerol. 2023; 158(1):15-20. doi: 10.23736/S2784-8671.22.07461-8

Cramer P, Stockfleth E. Actinic keratosis: where do we stand and where is the future going to take us? Expert Opin Emerg Drugs. 2020; 25(1):49-58. doi: 10.1080/14728214.2020.173081

Dianzani C, Conforti C, Giuffrida R, Corneli P, di Meo N, Farinazzo E, et al Current therapies for actinic keratosis. Int J Dermatol. 2020; 59(6):677-684. doi: 10.1111/ijd.14767

Kircik LH. Addressing the Challenges of Treating Actinic Keratosis. J Drugs Dermatol. 2019; 18(5):s160.

Lozada-Martinez ID, Suarez-Causado A, Solana-Tinoco JB. Ethnicity, genetic variants, risk factors and cholelithiasis: The need for eco-epidemiological studies and genomic analysis in Latin American surgery. Int J Surg. 2022; 99:106589. doi: 10.1016/j.ijsu.2022.106589

Pérez-Fontalvo NM, De Arco-Aragón MA, Jimenez-García JDC, Lozada-Martinez ID. Molecular and computational research in low- and middle-income countries: Development is close at hand. J Taibah Univ Med Sci. 2021; 16(6):948-949. doi: 10.1016/j.jtumed.2021.06.010